Rima Azar1, Darren Mercer. 1. Psychobiology of Stress & Health Lab, Psychology Department, Mount Allison University, Sackville, New Brunswick, Canada. razar@mta.ca
Abstract
BACKGROUND: We examined depressive symptoms, C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels during early to-midgestation. METHODS: We measured depressive symptoms on the Patient Health Questionnaire-9 (PHQ-9), and serum CRP, IL-6, and TNF-α levels twice in 27 pregnant women. RESULTS: After adjustment, depressive symptoms prospectively (β=0.42, p<0.05 at 16-20 weeks of gestation) and concurrently (β=0.54, p<0.01 at 7-10 weeks of gestation) predicted elevated CRP [F (2, 14)=9.20, p=0.003, R(2)=0.57 and F (3, 15)=9.08, p=0.001, R(2)=0.64, respectively]. There were similar patterns of results for TNF-α (β=0.72, p<0.01) and IL-6 levels (β=0.39, p<0.05) at 7-10 weeks of gestation [F (2,19)=8.84, p=0.002, R(2)=0.48]. Furthermore, the association between depressive symptoms at 7-10 weeks of gestation and increased IL-6 levels at 16-20 weeks of gestation approached statistical significance. We confirmed the findings with the Wilcoxon signed rank test (IL-6: Z=2.44, p=0.015; TNF-α: Z=1.94, p=0.05; CRP: approached statistical significance). CONCLUSIONS: These pilot data suggest that depressive symptoms may be associated with inflammatory markers during early to-midgestation.
BACKGROUND: We examined depressive symptoms, C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels during early to-midgestation. METHODS: We measured depressive symptoms on the Patient Health Questionnaire-9 (PHQ-9), and serum CRP, IL-6, and TNF-α levels twice in 27 pregnant women. RESULTS: After adjustment, depressive symptoms prospectively (β=0.42, p<0.05 at 16-20 weeks of gestation) and concurrently (β=0.54, p<0.01 at 7-10 weeks of gestation) predicted elevated CRP [F (2, 14)=9.20, p=0.003, R(2)=0.57 and F (3, 15)=9.08, p=0.001, R(2)=0.64, respectively]. There were similar patterns of results for TNF-α (β=0.72, p<0.01) and IL-6 levels (β=0.39, p<0.05) at 7-10 weeks of gestation [F (2,19)=8.84, p=0.002, R(2)=0.48]. Furthermore, the association between depressive symptoms at 7-10 weeks of gestation and increased IL-6 levels at 16-20 weeks of gestation approached statistical significance. We confirmed the findings with the Wilcoxon signed rank test (IL-6: Z=2.44, p=0.015; TNF-α: Z=1.94, p=0.05; CRP: approached statistical significance). CONCLUSIONS: These pilot data suggest that depressive symptoms may be associated with inflammatory markers during early to-midgestation.
Authors: Gregory E Miller; Cinnamon A Stetler; Robert M Carney; Kenneth E Freedland; William A Banks Journal: Am J Cardiol Date: 2002-12-15 Impact factor: 2.778
Authors: Emma Robertson Blackmore; Jan A Moynihan; David R Rubinow; Eva K Pressman; Michelle Gilchrist; Thomas G O'Connor Journal: Psychosom Med Date: 2011-09-23 Impact factor: 4.312
Authors: Kartik K Venkatesh; John D Meeker; David E Cantonwine; Thomas F McElrath; Kelly K Ferguson Journal: J Perinatol Date: 2019-02-05 Impact factor: 2.521
Authors: Paolo Cassano; Eric Bui; Andrew H Rogers; Zandra E Walton; Rachel Ross; Mary Zeng; Mireya Nadal-Vicens; David Mischoulon; Amanda W Baker; Aparna Keshaviah; John Worthington; Elizabeth A Hoge; Jonathan Alpert; Maurizio Fava; Kwok K Wong; Naomi M Simon Journal: Aust N Z J Psychiatry Date: 2016-09-29 Impact factor: 5.744
Authors: Vaishali Tirumalaraju; Robert Suchting; Jonathan Evans; Laura Goetzl; Jerrie Refuerzo; Alexander Neumann; Deepa Anand; Rekha Ravikumar; Charles E Green; Philip J Cowen; Sudhakar Selvaraj Journal: JAMA Netw Open Date: 2020-06-01
Authors: Daniel da Silveira; Nícollas Nunes Rabelo; Mateus Gonçalves de Sena Barbosa; Gustavo Frigeri; José Carlos Rebuglio Vellosa Journal: Surg Neurol Int Date: 2021-05-31